BCRX vs ITW · rev $374.7M vs P/E 22, rev $8.32B
BioCryst Pharmaceuticals Inc (BCRX) versus Illinois Tool Works Inc (ITW) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported ITW revenue for 2026-06-30 was $8.32B. Net income was $1.58B. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
BCRX currently screens at market cap $1.83B. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Not investment advice. Open the BCRX and ITW stock pages for the full models.
Not investment advice.